Voloridge Investment Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
Voloridge Investment Management's RGEN Position: Q4 2025 in Review
Voloridge Investment Management sold out of Repligen (RGEN) in Q4 2025, closing a stake of 141,042 shares — an estimated $18.9M sold.
Voloridge Investment Management first reported a position in RGEN in Q4 2018 and held it in 19 quarters. The position peaked at $21.8M in Q3 2021. 473 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.
- Voloridge Investment Management reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
- Voloridge Investment Management sold 141,042 Repligen shares in Q4 2025, an estimated $18.9M.
- Voloridge Investment Management first reported a position in Repligen in Q4 2018 and held it in 19 quarters.
- Voloridge Investment Management's Repligen position peaked at $21.8M in Q3 2021.
- 473 funds tracked by Wall St. Rank held Repligen as of Q4 2025.
Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.